Outlook Therapeutics (41O.F) Q2 2026 Earnings

14MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.38
-0.27
-0.16
-0.05

Details

Expected EPS
-0.10350448641
Actual EPS
N/A
Surprise EPS
0.1
Surprise Percent
+100%

Description

Outlook Therapeutics (41O.F) will report earnings of for Q2 2026 on May 14, 2026.

0 Comments

Share your thoughts